Citation Impact
Citing Papers
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Interleukin‐29 uses a type 1 interferon‐like program to promote antiviral responses in human hepatocytes†
2006
Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow Microenvironment
2007
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Cyclin A in cell cycle control and cancer
2002
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms
2004
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Functional and physical communication between oncoproteins and tumor suppressors
2005
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
2013
p21 in cancer: intricate networks and multiple activities
2009 Standout
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Long-term follow-up after successful interferon therapy of acute hepatitis C
2004
Cyclin A1 is required for meiosis in the male mouse
1998
SOCS regulation of the JAK/STAT signalling pathway
2008 Standout
Reflecting on 25 years with MYC
2008 Standout
Pyroptosis: A new frontier in cancer
2019 Standout
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy
2010
Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy
2003
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
2004
DNA methylation changes in multiple myeloma
2004
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Matrix metalloproteinases and tumor metastasis
2006 Standout
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†
2004
Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells
2003
TIMP-1 Alters Susceptibility to Carcinogenesis
2004
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
2003
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
2005 Standout
Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection
2008 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis of Human Cyclin a Starts at the Beginning of Mitosis and Is Not Subject to the Spindle Assembly Checkpoint
2001 StandoutNobel
Adult hematopoietic stem cells lacking Hif-1α self-renew normally
2016 StandoutNobel
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO
2007
GLUTATHIONE TRANSFERASES
2004 Standout
Genetics and Cytogenetics of Multiple Myeloma
2004
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification
2008
Comparison of Qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and Quantitative (COBAS AMPLICOR HCV Monitor 2.0 versus VERSANT HCV RNA 3.0) Assays for Hepatitis C Virus (HCV) RNA Detection and Quantification: Impact on Diagnosis and Treatment of HCV Infections
2005
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of A. Krämer being referenced
Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma
2002
Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay
2002
Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation
1998
Centrosome replication, genomic instability and cancer
2002
Analysis of p73 and p53 gene deletions in multiple myeloma
1999